Optune Lua is FDA approved for use with immunotherapy or docetaxel in metastatic stage IV NSCLC post-platinum treatment. The device uses tumor treating fields to disrupt cancer cell division ...

New Delhi: NovoCure, a US-based company, recently received FDA approval for its wearable device to treat metastatic cancer using Tumor Treating Fields (TTFields) technology. This non-invasive ...

Most notably, 226 of 521 FDA-approved medical devices, or approximately 43%, lacked published clinical validation data. A few ...

Some of the most exciting advances in migraine treatment technology aren’t medications but devices. The U.S. Food and Drug Administration (FDA ... which was approved for migraine prevention ...

Novocure received a long-sought FDA approval for the use of its Tumor Treating ... Its portable Optune Lua device, with arrays on adhesive patches worn on the chest or back, received a green ...

The FDA has approved a digital device developed by Cognoa that can be used to diagnose autism spectrum disorder (ASD), just a few weeks after it was filed for approval.

We need more science in the FDA approval process.” Spotlighting the issue is a new study in the Annals of Internal Medicine looking at recalls of heart devices -- like pacemakers, stents ...

The FDA cleared the device for use with immunotherapy or chemotherapy in people whose cancer has spread and progressed following chemo. Approval was based on results from “Lunar,” a Phase 3 ...

Medtech company DermaSensor has claimed FDA approval for a handheld device, powered by artificial intelligence (AI), that can be used to detect skin cancer at the point of care. The eponymous ...

“Receiving FDA approval to initiate this pivotal study marks a significant milestone in our efforts to bring this breakthrough hearing device to more people with severe to profound hearing loss ...